Oncology

News

Gilead’s CD47 woes continue, this time in solid tumours

Just a week after dropping the development of its CD47-targeting antibody magrolimab in blood cancers, Gilead Sciences has paused enrolment in clinical trials of the drug

News

Astellas pledges $800m to Kelonia CAR-T alliance in cancer

Astellas has signed an R&D and licensing deal with Kelonia Therapeutics that aims to develop CAR-T therapies for cancer that will push the boundaries of what can be ac

News

Innsena backs CancerX’s digital drive to improve access

Healthtech consultancy Innsena has committed funding and expertise to The White House’s CancerX initiative, launched last year to encourage the use of digital technologies

News

Roche, PathAI team up on AI companion diagnostics

Roche has turned to artificial intelligence specialist PathAI to accelerate development of digital pathology technologies that can be used to match patients with drug treatments and s

News

Gilead drops CD47 drug magrolimab for blood cancers

Gilead Sciences has said it will no longer develop its CD47-targeting antibody magrolimab in blood cancers after data suggested that patients taking the drug in clinical t

News

NHS England pushes BRCA testing for Jewish community

Jewish people in England are being invited to take part in a gene testing programme to identify carriers of BRCA mutations that elevate their risk of breast cancer.

Gilead’s CD47 woes continue, this time in solid tumours

Astellas pledges $800m to Kelonia CAR-T alliance in cancer

Innsena backs CancerX’s digital drive to improve access

Roche, PathAI team up on AI companion diagnostics

Gilead drops CD47 drug magrolimab for blood cancers

NHS England pushes BRCA testing for Jewish community

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Oncology

Editor's Picks